The Psychedelics & Pain Symposium 2025

The Psychedelics & Pain Symposium 2025 is the only conference highlighting past, current, and ongoing investigations into how psychedelics can treat chronic pain and related physical conditions, such as neurodegenerative, autoimmune, and infection-acquired chronic illness.

Founded in 2022, each year the Symposium highlights top research from around the world, this year including findings and patient stories about phantom-limb pain, fibromyalgia, Complex Regional Pain Syndrome, Long-COVID, cluster headache, spinal cord injury, neuropathic pain, cancer-induced bone pain, and other physical conditions. Psychedelics have shown unique promise and enduring relief for many conditions where standard-of-care medications are often ineffective. Researchers frequently share early study results, giving our audience advanced insight into the efficacy and mechanisms of action involved in providing patients with profound relief.

As evidence builds, patient communities are sharing their real-world results & protocols for self-treating debilitating conditions, while building best practices for ensuring safe and effective delivery. The Symposium includes multiple in-person case studies describing their personal experiences in using psychedelic medicines, their previous history of other interventions, and how psychedelics have made striking improvements in their quality of life.

A full recording of the event will be available to all paid attendees and to those who couldn’t attend during the event time.